Efficacy of Vedolizumab (VDZ) by Disease Extension in Ulcerative Colitis (UC)

被引：0
|
作者：
Michetti, Pierre [1 ,2 ]
Braegger, Fiona [3 ]
Kempf, Christian [3 ]
Allez, Matthieu [4 ]
机构：
[1] CHU Vaudois, Gastroenterol La Source Beaulieu, Lausanne, Switzerland
[2] CHU Vaudois, Div Gastroenterol, Lausanne, Switzerland
[3] Takeda Pharmaceut Int AG, Zurich, Switzerland
[4] Univ Paris 07, Hop St Louis, AP HP, Dept Gastroenterol & Hepatol,INSERM,UMRS 1160, Paris, France
来源：
SWISS MEDICAL WEEKLY | 2018年 / 148卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G38
引用
收藏
页码：22S / 22S
页数：1
相关论文
共 50 条
  • [1] Efficacy of vedolizumab (VDZ) by disease extension in ulcerative colitis
    Michetti, P.
    Braegger, F.
    Kempf, C.
    Allez, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S402 - S403
  • [2] VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC)
    Pulusu, Samba Siva Reddy
    Srinivasan, Ashish
    Krishnaprasad, Krupa
    Cheng, Daniel
    Mogilevski, Tamara
    Flanagan, Emma
    Keung, Charlotte
    Wu, Yang
    Prosser, Ruth
    Sawyer, Elise A.
    Rizvi, Quart-Ul-Ain
    Su, Heidi Y.
    Leung, Wai K.
    Edmundson, Aleksandra
    Cooke, Sharon
    Mahy, Gillian
    Thin, Lena
    Radford-Smith, Graham L.
    Sparrow, Miles
    Andrews, Jane M.
    Connor, Susan J.
    Bampton, Peter A.
    Simon, Ghaly
    van Langenberg, Daniel R.
    Bell, Sally
    De Cruz, Peter
    Begun, Jakob
    Ng, Siew C.
    Travis, Simon P.
    Lawrance, Ian
    GASTROENTEROLOGY, 2018, 154 (06) : S836 - S836
  • [3] Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)
    Pulusu, S. S. R.
    Srinivasan, A.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Keung, C.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q. -U. -A.
    Su, H.
    Leung, W. -K.
    Edmundson, A.
    Cooke, S.
    Mahy, G.
    Thin, L.
    Radford-Smith, G.
    Sparrow, M.
    Andrews, J. M.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Ng, S.
    Travis, S.
    Lawrance, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S395 - S396
  • [4] Maintenance therapy of vedolizumab (VDZ) after induction of remission by tacrolimus (TAC) in patients with refractory ulcerative colitis (UC)
    Ito, A.
    Shun, M.
    Teppei, O.
    Katsutoshi, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S377 - S378
  • [5] Efficacy of vedolizumab (VDZ) by disease localisation in Crohn's disease
    Allez, M.
    Braegger, F.
    Kempf, C.
    Michetti, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S479 - S479
  • [6] Predictors of the efficacy of vedolizumab in patients with ulcerative colitis
    Kajikawa, Go
    Sawada, Tsunaki
    Nakamura, Masanao
    Yamamura, Takeshi
    Maeda, Keiko
    Ishikawa, Eri
    Uetsuki, Kota
    Hirose, Takashi
    Iida, Tadashi
    Mizutani, Yasuyuki
    Yamao, Kentaro
    Ishikawa, Takuya
    Furukawa, Kazuhiro
    Kawashima, Hiroki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2024, 86 (03): : 407 - 421
  • [7] Efficacy and safety of vedolizumab in the treatment of ulcerative colitis
    Domenech, Eugeni
    Gisbert, Javier P.
    Gastroenterologia y Hepatologia, 2016, 39 (10): : 677 - 686
  • [8] Efficacy of Vedolizumab (VDZ) by Disease Localisation in Crohn's Disease (CD)
    Allez, Matthieu
    Braegger, Fiona
    Kempf, Christian
    Michetti, Pierre
    SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
  • [9] Efficacy and safety of vedolizumab in the maintenance phase of ulcerative colitis
    Torralba, K. S.
    Payawal, D. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 267 - 268
  • [10] Efficacy and Safety of Retreatment With Vedolizumab in Patients With Ulcerative Colitis
    Sands, Bruce E.
    Shafran, Ira
    Farraye, Francis A.
    Cheifetz, Adam S.
    Abhyankar, Brihad
    Sankoh, Serap
    Smyth, Michael D.
    GASTROENTEROLOGY, 2015, 148 (04) : S278 - S278
12345